Our strategy is to capitalise on the increasing trend among pharmaceutical, biotech and medtech companies to outsource non-core and specialist activities on an international basis.
We aim to leverage our existing strong market positions, offer innovative solutions and create demand for our specialist services, thereby driving higher levels of growth and profitability. We achieve this by focussing on three strategic framework pillars which we apply across each business unit to deliver our strategy.
- Develop and Expand Market-Leading Positions
- Drive Productivity
- Lead Through People
Develop And Expand Market-Leading Positions
We believe scale in major markets, international reach and reputation are key to business development success. We aim to be a leading operator in each of our priority markets and to expand our positions in growth markets.
Geographic and Services Expansion
We will continue to expand our activities organically across our core markets of the US, Europe and Japan. Our organic service development and expansion will be enhanced by strategic acquisitions of complementary services and capabilities. The Group has a track record of successfully acquiring and integrating businesses to deliver a return on capital in excess of 15%.
Client Focus & Commercial Excellence
We work in partnership with our clients to develop, adapt and create new and bespoke solutions to help them achieve their objectives. This helps our clients succeed in a continuously changing and complex operating environment.
Supplementary Sources of Growth
We continually aim to innovate and improve our service offering to capitalise fully on growth opportunities. This allows us to differentiate our service offering and leverage our market positions by enhancing the range of capabilities we can offer our clients.
We aim to consistently improve our operating efficiencies across the Group. We do this through benchmarking our commercial and financial performance against specific Key Performance Indicators (KPIs).
We drive and measure continuous improvement across the Group to ensure we offer best-in-class service to our clients. We monitor our businesses against six financial and three nonfinancial KPIs. Our KPIs support the execution of our strategy and are important drivers of improved business performance over the short, medium and long term.
We aim to continually increase margins to drive improved profitability. Improving productivity and increasing operational efficiencies are a key focus of our organic growth strategy to drive the expansion of business unit, divisional and Group margins.
We deploy capital in areas where we identify the greatest strategic benefit and financial return, while maintaining relatively low levels of financial risk in the Group. We will invest in scalable infrastructure to support the delivery of sustainable future growth, ensuring there is a robust infrastructure in place to manage the existing business and to integrate future acquisitions.
Lead Through People
We are a people-based business operating in dynamic healthcare markets that are highly regulated and demand high quality and compliance standards. We are building our culture by living our Values and developing our talent by encouraging the Ingenuity and Expertise necessary to support our client’s ambitions.
Talent and Leadership
We invest in the development of our people, empowering and enabling them to be the best they can be. We build, attract and encourage entrepreneurial leadership teams, often with acquired businesses that are capable of delivering outstanding performance.
Quality and Compliance
Our service offerings are underpinned by a strong quality and compliance structure. This enables our clients to outsource with confidence.
Values Based Culture
Our Values define our culture and unite us in delivering our vision of improving patients’ lives. We aim to integrate these Values into everything we do, from our people processes to daily interactions with our clients.